Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Johnson

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Nature Immunology|June 27, 2025
The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8<sup>+</sup> T cell exhaustionMichael S Dahabieh, Lisa M DeCamp, Brandon M Oswald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2025
Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrierTyler C Moyer, Brett A Hoffman, Weitong Chen, et al.
Molecular Cancer Therapeutics|September 29, 2021
Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor ActivityDirk Brehmer, Lijs Beke, Tongfei Wu, et al.
G3 (Bethesda, Md.)|March 6, 2015
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolutionWilson Leung, Christopher D Shaffer, Laura K Reed, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Nature Immunology|June 27, 2025
The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8<sup>+</sup> T cell exhaustionMichael S Dahabieh, Lisa M DeCamp, Brandon M Oswald, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2025
Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrierTyler C Moyer, Brett A Hoffman, Weitong Chen, et al.
Molecular Cancer Therapeutics|September 29, 2021
Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor ActivityDirk Brehmer, Lijs Beke, Tongfei Wu, et al.
G3 (Bethesda, Md.)|March 6, 2015
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolutionWilson Leung, Christopher D Shaffer, Laura K Reed, et al.
Pageof 15